Investors with a lot of money to spend have taken a bullish stance on Moderna (NASDAQ:MRNA).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MRNA, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 10 uncommon options trades for Moderna.
This isn't normal.
The overall sentiment of these big-money traders is split between 70% bullish and 10%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $203,756, and 6 are calls, for a total amount of $250,820.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $190.0 for Moderna during the past quarter.
Volume & Open Interest Trends
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $50.0 to $190.0 in the last 30 days.
Moderna Call and Put Volume: 30-Day Overview
Largest Options Trades Observed:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
MRNA | PUT | TRADE | NEUTRAL | 06/07/24 | $4.8 | $4.55 | $4.68 | $130.00 | $93.6K | 327 | 200 |
MRNA | CALL | SWEEP | BULLISH | 05/17/24 | $25.75 | $23.1 | $25.4 | $105.00 | $88.8K | 993 | 35 |
MRNA | CALL | TRADE | BULLISH | 07/19/24 | $5.8 | $5.65 | $5.8 | $140.00 | $58.0K | 2.9K | 105 |
MRNA | PUT | SWEEP | BULLISH | 07/19/24 | $6.25 | $5.05 | $5.2 | $125.00 | $54.9K | 1.9K | 30 |
MRNA | PUT | SWEEP | BULLISH | 09/20/24 | $1.91 | $1.73 | $1.73 | $95.00 | $28.3K | 1.6K | 172 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Following our analysis of the options activities associated with Moderna, we pivot to a closer look at the company's own performance.
Present Market Standing of Moderna
- With a volume of 876,007, the price of MRNA is down -0.14% at $132.5.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 76 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
有大量資金可以花的投資者對Moderna(NASDAQ:MRNA)採取了看漲立場。
零售交易者應該知道。
今天,當交易出現在我們在本辛加追蹤的公開期權歷史記錄上時,我們注意到了這一點。
這些是機構還是僅僅是富人,我們都不知道。但是,當 MRNA 發生這麼大的事情時,這通常意味着有人知道某件事即將發生。
那麼我們怎麼知道這些投資者剛才做了什麼?
今天,Benzinga的期權掃描儀發現了Moderna的10筆不常見的期權交易。
這不正常。
這些大資金交易者的整體情緒介於70%的看漲和10%的看跌之間。
在我們發現的所有特殊期權中,有4個是看跌期權,總額爲203,756美元;6個是看漲期權,總額爲250,820美元。
預計價格目標
分析這些合約的交易量和未平倉合約,看來大型企業一直在關注Moderna在過去一個季度的價格範圍從50.0美元到190.0美元不等。
交易量和未平倉合約趨勢
交易期權時,查看交易量和未平倉合約是一個強有力的舉動。這些數據可以幫助您跟蹤給定行使價下Moderna期權的流動性和利息。下面,我們可以分別觀察過去30天中Moderna所有鯨魚交易的看漲期權和看跌期權交易量和未平倉合約的變化,其行使價在50.0美元至190.0美元之間。
Moderna 看漲期權和看跌交易量:30 天概覽
觀察到的最大期權交易:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
MRNA | PUT | TRADE | NEUTRAL | 06/07/24 | $4.8 | $4.55 | $4.68 | $130.00 | $93.6K | 327 | 200 |
MRNA | CALL | SWEEP | BULLISH | 05/17/24 | $25.75 | $23.1 | $25.4 | $105.00 | $88.8K | 993 | 35 |
MRNA | CALL | TRADE | BULLISH | 07/19/24 | $5.8 | $5.65 | $5.8 | $140.00 | $58.0K | 2.9K | 105 |
MRNA | PUT | SWEEP | BULLISH | 07/19/24 | $6.25 | $5.05 | $5.2 | $125.00 | $54.9K | 1.9K | 30 |
MRNA | PUT | SWEEP | BULLISH | 09/20/24 | $1.91 | $1.73 | $1.73 | $95.00 | $28.3K | 1.6K | 172 |
關於 Moderna
Moderna是一家商業階段的生物技術公司,成立於2010年,並於2018年12月進行了首次公開募股。該公司的 mRNA 技術通過其 COVID-19 疫苗迅速得到驗證,該疫苗於 2020 年 12 月在美國獲得授權。截至2023年中期,Moderna在臨床試驗中有39個mRNA開發候選藥物。項目涵蓋廣泛的治療領域,包括傳染病、腫瘤學、心血管疾病和罕見遺傳病。
在分析了與Moderna相關的期權活動之後,我們將轉向仔細研究公司自身的表現。
Moderna 目前的市場地位
與僅交易股票相比,期權是一種風險更高的資產,但它們具有更高的獲利潛力。嚴肅的期權交易者通過每天自我教育、擴大交易規模、關注多個指標以及密切關注市場來管理這種風險。